These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 16954536)

  • 21. Blood-compatible biomaterials by surface coating with a novel antithrombin-heparin covalent complex.
    Klement P; Du YJ; Berry L; Andrew M; Chan AK
    Biomaterials; 2002 Jan; 23(2):527-35. PubMed ID: 11762330
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of glycosylation on heparin binding and antithrombin activation by heparin.
    Pol-Fachin L; Franco Becker C; Almeida Guimarães J; Verli H
    Proteins; 2011 Sep; 79(9):2735-45. PubMed ID: 21769943
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Conformational changes in serpins: II. The mechanism of activation of antithrombin by heparin.
    Whisstock JC; Pike RN; Jin L; Skinner R; Pei XY; Carrell RW; Lesk AM
    J Mol Biol; 2000 Sep; 301(5):1287-305. PubMed ID: 10966821
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemical-physical characterization of polyurethane catheters modified with a novel antithrombin-heparin covalent complex.
    Du YJ; Berry LR; Chan AK
    J Biomater Sci Polym Ed; 2011; 22(17):2277-94. PubMed ID: 21092417
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Importance of tryptophan 49 of antithrombin in heparin binding and conformational activation.
    Monien BH; Krishnasamy C; Olson ST; Desai UR
    Biochemistry; 2005 Sep; 44(35):11660-8. PubMed ID: 16128566
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Isoform composition of antithrombin in a covalent antithrombin-heparin complex.
    Chan AK; Berry LR; Paredes N; Parmar N
    Biochem Biophys Res Commun; 2003 Oct; 309(4):986-91. PubMed ID: 13679071
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo rabbit acute model tests of polyurethane catheters coated with a novel antithrombin-heparin covalent complex.
    Du YJ; Klement P; Berry LR; Tressel P; Chan AK
    Thromb Haemost; 2005 Aug; 94(2):366-72. PubMed ID: 16113827
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monitoring complex formation in the blood-coagulation cascade using aptamer-coated SAW sensors.
    Gronewold TM; Glass S; Quandt E; Famulok M
    Biosens Bioelectron; 2005 Apr; 20(10):2044-52. PubMed ID: 15741074
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dynamic properties of the native free antithrombin from molecular dynamics simulations: computational evidence for solvent- exposed Arg393 side chain.
    Tóth L; Fekete A; Balogh G; Bereczky Z; Komáromi I
    J Biomol Struct Dyn; 2015 Sep; 33(9):2023-36. PubMed ID: 25483839
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure of beta-antithrombin and the effect of glycosylation on antithrombin's heparin affinity and activity.
    McCoy AJ; Pei XY; Skinner R; Abrahams JP; Carrell RW
    J Mol Biol; 2003 Feb; 326(3):823-33. PubMed ID: 12581643
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selective cleavage of heparin using aqueous 2-hydroxypyridine: production of an aldose-terminating fragment with high anticoagulant activity.
    Berry LR; Parmar N; Hatton MW; Chan AK
    Biochem Biophys Res Commun; 2006 Aug; 346(3):946-57. PubMed ID: 16781674
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Crystal structure of antithrombin in a heparin-bound intermediate state.
    Johnson DJ; Huntington JA
    Biochemistry; 2003 Jul; 42(29):8712-9. PubMed ID: 12873131
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cyclic peptide analysis of the biologically active loop region in the laminin alpha3 chain LG4 module demonstrates the importance of peptide conformation on biological activity.
    Kato-Takagaki K; Suzuki N; Yokoyama F; Takaki S; Umezawa K; Higo J; Mochizuki M; Kikkawa Y; Oishi S; Utani A; Nomizu M
    Biochemistry; 2007 Feb; 46(7):1952-60. PubMed ID: 17261031
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Paramount Importance of Core Conformational Changes for Heparin Allosteric Activation of Antithrombin.
    Izaguirre G; Swanson R; Roth R; Gettins PGW; Olson ST
    Biochemistry; 2021 Apr; 60(15):1201-1213. PubMed ID: 33822598
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of conformational transformation of antithrombin in blood with crossed immunoelectrophoresis: new application for a classical method.
    Corral J; Rivera J; Martínez C; González-Conejero R; Miñano A; Vicente V
    J Lab Clin Med; 2003 Nov; 142(5):298-305. PubMed ID: 14647033
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of covalent antithrombin-heparin complex on developmental mechanisms in the lung.
    Parmar N; Berry LR; Post M; Chan AK
    Am J Physiol Lung Cell Mol Physiol; 2009 Mar; 296(3):L394-403. PubMed ID: 19112103
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The cleaved and latent forms of antithrombin are normal constituents of blood plasma: a quantitative method to measure cleaved antithrombin.
    Kjellberg M; Ikonomou T; Stenflo J
    J Thromb Haemost; 2006 Jan; 4(1):168-76. PubMed ID: 16409466
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PWWP module of human hepatoma-derived growth factor forms a domain-swapped dimer with much higher affinity for heparin.
    Sue SC; Lee WT; Tien SC; Lee SC; Yu JG; Wu WJ; Wu WG; Huang TH
    J Mol Biol; 2007 Mar; 367(2):456-72. PubMed ID: 17270212
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thromboembolic disease due to thermolabile conformational changes of antithrombin Rouen-VI (187 Asn-->Asp).
    Bruce D; Perry DJ; Borg JY; Carrell RW; Wardell MR
    J Clin Invest; 1994 Dec; 94(6):2265-74. PubMed ID: 7989582
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Replacement of Phe274 with conserved residue Tyr274 for reactive center loop expulsion in antithrombin.
    Duhan U
    Clin Appl Thromb Hemost; 2011 Jun; 17(3):273-8. PubMed ID: 20211924
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.